AstraZeneca PLC
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AZN.BA | 4503.T | LLY.NE | MRK | PFE | NVS | |
|---|---|---|---|---|---|---|
| Market cap | 123.69T | 4.79T | 1.74T | 370.96B | 175.50B | 311.59B |
| P/E (TTM) | 8.1 | 13.2 | 65.7 | 151.9 | 44.0 | 31.5 |
| Forward P/E | — | 35.3 | — | 16.7 | 10.6 | 16.6 |
| Price/book | 18.9 | 2.6 | 1.4 | 8.9 | 2.1 | 8.4 |
| Dividend yield | 1.44% | 3.11% | 0.58% | 2.26% | 5.59% | 2.87% |
| 1-year change | +25.85% | +47.30% | +35.37% | +75.29% | +23.90% | +30.35% |
| Today | +3.84% | +6.88% | +0.78% | +3.93% | +2.63% | +3.59% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All AZN.BA news ›Guggenheim Sticks to Their Buy Rating for AstraZeneca (AZN)
Guggenheim analyst reiterated a Buy rating on AstraZeneca yesterday and set a price target of £162.00. In addition to Guggenheim, AstraZeneca also received a Buy from Citi’s Graham Parry in a report issued yesterday. However, today,…
AstraZeneca shares jump 7% after beating Q3 estimates
AstraZeneca shares surged nearly 7% on Friday after the pharmaceutical company reported third-quarter revenue of $16.21 billion and core earnings per share of $2.79, both exceeding market forecasts. The stock move followed the release of a…
Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
In a cavernous office in London's AI hub, a group of researchers is preparing to do battle with humanity's oldest enemy. Isomorphic Labs, a spinoff of Google DeepMind and the brainchild of AI pioneer Demis Hassabis, has an ambitious…
Drugs giant AstraZeneca reveals higher profits, savings plan
London: British pharmaceutical group AstraZeneca announced Friday a 23-percent jump in net profit for the third quarter and a new programme aiming for annual savings of $1.5 billion. Profit after tax increased to $3.12 billion in the…
AstraZeneca Gaps Up To Three-Month High As CEO Calls Out $20 Billion Potential
BREAKING: Bitcoin Plunges As N. Korea Hacks Binance AstraZeneca (AZN) stock gapped higher Friday as cancer drugs Enhertu and Tagrisso lent themselves to a solid third-quarter report. Shares leaped to a three-month high inside a…
AstraZeneca is launching a $1.5 billion cost-savings program to fund its drug pipeline
The drugmaker expects one-time restructuring costs of up to $2 billion as it redeploys resources over three years AstraZeneca $AZN +2.88% is launching a cost-savings program with $1.5 billion in annualized benefits to free up money for its…
AstraZeneca Plc $AZN Shares Acquired by Brian Low Financial Group LLC
Posted by Defense World Staff on Oct 31st, 2026 Here are the key news stories impacting AstraZeneca this week: AstraZeneca plc is a global, science-led biopharmaceutical company headquartered in Cambridge, United Kingdom. The company…
AstraZeneca (NYSE:AZN) Share Price Crosses Above 200 Day Moving Average – Time to Sell?
Posted by Defense World Staff on Oct 31st, 2026 AstraZeneca Plc (NYSE:AZN – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $180.21 and traded as…
AstraZeneca (AZN) Stock Surges Following $46.9 Billion Nine-Month Revenue Performance
AstraZeneca delivered total revenue of $46.9 billion throughout the initial nine months of 2026. This performance reflected a 7% increase when measured at constant exchange rates, with product sales contributing $46.8 billion to the total.…
AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026 outlook
AstraZeneca PLC press release (AZN): Q3 Non-GAAP EPS of $2.79. Revenue of $16.21B (+6.7% Y/Y) beats by $210M. FY2026 Guidance AstraZeneca reconfirms: Total Reve - AstraZeneca PLC press release (AZN): Q3 Non-GAAP EPS of $2.79. - Revenue of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com91
- tradingview.com15
- seekingalpha.com13
- stocktitan.net11
- themarketsdaily.com10
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.